메뉴 건너뛰기




Volumn 8, Issue 6, 2007, Pages 401-407

Sick day management in children and adolescents with diabetes

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTIPYRETIC AGENT; GLUCAGON; IBUPROFEN; INSULIN; KETONE; PARACETAMOL; PROMETHAZINE;

EID: 36448995423     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2007.00351.x     Document Type: Article
Times cited : (19)

References (25)
  • 1
    • 33644960034 scopus 로고    scopus 로고
    • Increased risk of infection in patients with diabetes mellitus type 1 or 2
    • Muller LM, Gorter KJ, Hak E et al. [Increased risk of infection in patients with diabetes mellitus type 1 or 2]. Ned Tijdschr Geneeskd 2006: 150: 549-553.
    • (2006) Ned Tijdschr Geneeskd , vol.150 , pp. 549-553
    • Muller, L.M.1    Gorter, K.J.2    Hak, E.3
  • 2
    • 0015984043 scopus 로고
    • Impaired leukocyte function in patients with poorly controlled diabetes
    • Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 1974: 23: 9-15.
    • (1974) Diabetes , vol.23 , pp. 9-15
    • Bagdade, J.D.1    Root, R.K.2    Bulger, R.J.3
  • 3
    • 29544436669 scopus 로고    scopus 로고
    • Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus
    • Liberatore RR Jr, Barbosa SF, Alkimin MG et al. Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 2005: 6: 206-212.
    • (2005) Pediatr Diabetes , vol.6 , pp. 206-212
    • Liberatore Jr., R.R.1    Barbosa, S.F.2    Alkimin, M.G.3
  • 5
    • 0033400713 scopus 로고    scopus 로고
    • Ketone bodies: A review of physiology, pathophysiology and application of monitoring to diabetes
    • Laffel L. Ketone bodies: A review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 1999: 15: 412-426.
    • (1999) Diabetes Metab Res Rev , vol.15 , pp. 412-426
    • Laffel, L.1
  • 6
    • 25844505863 scopus 로고    scopus 로고
    • Advantages to using capillary blood beta-hydroxybutyrate determination for the detection and treatment of diabetic ketosis
    • Guerci B, Tubiana-Rufi N, Bauduceau B et al. Advantages to using capillary blood beta-hydroxybutyrate determination for the detection and treatment of diabetic ketosis. Diabetes Metab 2005: 31: 401-406.
    • (2005) Diabetes Metab , vol.31 , pp. 401-406
    • Guerci, B.1    Tubiana-Rufi, N.2    Bauduceau, B.3
  • 7
    • 0036416148 scopus 로고    scopus 로고
    • When should determination of ketonemia be recommended?
    • Samuelsson U, Ludvigsson J. When should determination of ketonemia be recommended? Diabetes Technol Ther 2002: 4: 645-650.
    • (2002) Diabetes Technol Ther , vol.4 , pp. 645-650
    • Samuelsson, U.1    Ludvigsson, J.2
  • 8
    • 0042668620 scopus 로고    scopus 로고
    • Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients
    • Guerci B, Benichou M, Floriot M et al. Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients. Diabetes Care 2003: 26: 1137-1141.
    • (2003) Diabetes Care , vol.26 , pp. 1137-1141
    • Guerci, B.1    Benichou, M.2    Floriot, M.3
  • 9
    • 0028854827 scopus 로고
    • Clinical utility of beta-hydroxybutyrate determined by reflectance meter in the management of diabetic ketoacidosis
    • Umpierrez GE, Watts NB, Phillips LS. Clinical utility of beta-hydroxybutyrate determined by reflectance meter in the management of diabetic ketoacidosis. Diabetes Care 1995: 18: 137-138.
    • (1995) Diabetes Care , vol.18 , pp. 137-138
    • Umpierrez, G.E.1    Watts, N.B.2    Phillips, L.S.3
  • 10
    • 0034839436 scopus 로고    scopus 로고
    • The hospital and home use of a 30-second hand-held blood ketone meter: Guidelines for clinical practice
    • Wallace TM, Meston NM, Gardner SG, Matthews DR. The hospital and home use of a 30-second hand-held blood ketone meter: Guidelines for clinical practice. Diabet Med 2001: 18: 640-645.
    • (2001) Diabet Med , vol.18 , pp. 640-645
    • Wallace, T.M.1    Meston, N.M.2    Gardner, S.G.3    Matthews, D.R.4
  • 11
    • 25844471129 scopus 로고    scopus 로고
    • Sick day management (SDM) using blood β-hydroxybutyrate (βOHB) vs. urine ketones significantly reduces hospital visits in youth with T1DM: A randomized clinical trial
    • (Abstract)
    • Laffel L, Loughlin C, Tovar A, Zuehlke J, Brink S. Sick day management (SDM) using blood β-hydroxybutyrate (βOHB) vs. urine ketones significantly reduces hospital visits in youth with T1DM: A randomized clinical trial. Diabetes 2002: 51 (Suppl. 2): A105 (Abstract).
    • (2002) Diabetes , vol.51 , Issue.SUPPL. 2
    • Laffel, L.1    Loughlin, C.2    Tovar, A.3    Zuehlke, J.4    Brink, S.5
  • 12
    • 33645056189 scopus 로고    scopus 로고
    • Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: A randomized clinical trial
    • Laffel LM, Wentzell K, Loughlin C, Tovar A, Moltz K, Brink S. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: A randomized clinical trial. Diabet Med 2006: 23: 278-284.
    • (2006) Diabet Med , vol.23 , pp. 278-284
    • Laffel, L.M.1    Wentzell, K.2    Loughlin, C.3    Tovar, A.4    Moltz, K.5    Brink, S.6
  • 14
    • 36448941651 scopus 로고    scopus 로고
    • Type 1 diabetes in children, adolescents and young adults
    • In: London: Class Publishing
    • Hanas R. Type 1 diabetes in children, adolescents and young adults. In: How to Become an Expert on your Own Diabetes. London: Class Publishing, 2007.
    • (2007) How to Become an Expert on Your Own Diabetes
    • Hanas, R.1
  • 15
    • 0034820852 scopus 로고    scopus 로고
    • Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes
    • Haymond MW, Schreiner B. Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes. Diabetes Care 2001: 24: 643-645.
    • (2001) Diabetes Care , vol.24 , pp. 643-645
    • Haymond, M.W.1    Schreiner, B.2
  • 16
    • 33644827331 scopus 로고    scopus 로고
    • Mini-dose glucagon rescue for mild hypoglycaemia in children with type 1 diabetes: The Brisbane experience
    • Hartley M, Thomsett MJ, Cotterill AM. Mini-dose glucagon rescue for mild hypoglycaemia in children with type 1 diabetes: The Brisbane experience. J Paediatr Child Health 2006: 42: 108-111.
    • (2006) J Paediatr Child Health , vol.42 , pp. 108-111
    • Hartley, M.1    Thomsett, M.J.2    Cotterill, A.M.3
  • 17
    • 0032847214 scopus 로고    scopus 로고
    • Diabetic ketoacidosis: Prevention, treatment and complications in children and adolescents
    • Brink SJ. Diabetic ketoacidosis: Prevention, treatment and complications in children and adolescents. Diabetes Nutr Metab 1999: 12: 122-135.
    • (1999) Diabetes Nutr Metab , vol.12 , pp. 122-135
    • Brink, S.J.1
  • 19
    • 0034544916 scopus 로고    scopus 로고
    • Sick-day management in type 1 diabetes
    • Laffel L. Sick-day management in type 1 diabetes. Endocrinol Metab Clin North Am 2000: 29: 707-723.
    • (2000) Endocrinol Metab Clin North Am , vol.29 , pp. 707-723
    • Laffel, L.1
  • 20
    • 0042183726 scopus 로고    scopus 로고
    • Denver, CO: Children's Diabetes Foundation
    • Chase HP. Understanding Diabetes. Denver, CO: Children's Diabetes Foundation, 2006.
    • (2006) Understanding Diabetes
    • Chase, H.P.1
  • 21
    • 24144466849 scopus 로고    scopus 로고
    • Australian Government, National Health and Medical Research Council. (available from)
    • Australian Government, National Health and Medical Research Council. Clinical Practice Guidelines: Type 1 Diabetes in Children and Adolescents 2005 (available from http://www.nhmrc.gov.au/publications/ synopses/cp102syn.htm).
    • (2005) Clinical Practice Guidelines: Type 1 Diabetes in Children and Adolescents
  • 24
    • 1242305017 scopus 로고    scopus 로고
    • Parameters: Correction factor, CF (1700 rule), carbohydrate-to-insulin ratio, CIR (2.8 rule), and basal-to-total ratio
    • (Abstract)
    • Davidson P, Hebblewhite H, Bode B et al. Parameters: Correction factor, CF (1700 rule), carbohydrate-to-insulin ratio, CIR (2.8 rule), and basal-to-total ratio. Diabetes Technol Ther 2003: 5: 237 (Abstract).
    • (2003) Diabetes Technol Ther , vol.5 , pp. 237
    • Davidson, P.1    Hebblewhite, H.2    Bode, B.3
  • 25
    • 36448993136 scopus 로고    scopus 로고
    • Can the introduction of carbohydrate counting algorithms integrated into pump therapy decrease HbA1c in the children and adolescents with type 1 diabetes?
    • (Abstract)
    • Enander R, Carlzon E, Chaplin J et al. Can the introduction of carbohydrate counting algorithms integrated into pump therapy decrease HbA1c in the children and adolescents with type 1 diabetes? Pediatr Diabetes 2007: 8 (Suppl. 7): 80 (Abstract).
    • (2007) Pediatr Diabetes , vol.8 , Issue.SUPPL. 7 , pp. 80
    • Enander, R.1    Carlzon, E.2    Chaplin, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.